1. Home
  2. NTLA
  3. NTLA News

Latest Intellia Therapeutics Inc. (NTLA) News on June 23, 2025

MT Newswires

a month ago

Top Premarket Gainers

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Intellia Therapeutics Inc Earnings Call

Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema

Clinical Trials Arena

5 months ago

Intellia doses first subject in trial of NTLA-2002 for hereditary angioedema

Share on Social Networks: